drugset / Trial / NCT03275792
Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will provide feasibility data regarding the conduct of a clinical trail evaluating the use of early aggressive inpatient intravenous rehydration in children with Shiga Toxin producing E. coli infection.
Timeline
- Start
- 2020-05
- Primary completion
- 2021-04
- Completion
- 2021-04
Outcome
Outcome not reported
Stopped (Business): “Funding not obtained.”
Publications
- Imdad A, Nelson JR, Tanner-Smith EE, Huang D, Gomez-Duarte OG. Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome. Cochrane Database Syst Rev. 2025 Apr 25;4(4):CD012997. doi: 10.1002/14651858.CD012997.pub3.
- Imdad A, Mackoff SP, Urciuoli DM, Syed T, Tanner-Smith EE, Huang D, Gomez-Duarte OG. Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome. Cochrane Database Syst Rev. 2021 Jul 5;7(7):CD012997. doi: 10.1002/14651858.CD012997.pub2.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D5-0.9%NS | Unknown | — | Intravenous |
| Comparator | Routine home oral rehydration | Unknown | — | Oral |